Proteins and Peptides

18 Sep 2017 U.S. FDA Approves New Indication for Ipsen's Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
18 Sep 2017 ThromboGenics NV : ThromboGenics Regains Global Rights to JETREA® (ocriplasmin)
15 Sep 2017 Bydureon EXSCEL Trial Demonstrates Favorable Cardiovascular (CV) Safety Profile and Fewer CV Events in Patients with Type-2 Diabetes at Wide Range of CV Risk
15 Sep 2017 Tresiba® trial shows that people with type 2 diabetes who avoid severe hypoglycaemia have a reduced risk of deat
14 Sep 2017 Engineered Therapy for Blood Clotting Disorder Shows Early Promise
13 Sep 2017 Xultophy® reduces cardiovascular risk factors in people with type 2 diabetes
13 Sep 2017 Bioniz Therapeutics Presents Data Demonstrating the Synergistic Effects of Cytokines IL-15 and IL-21 in Celiac Disease Pathogenesis
12 Sep 2017 Fiasp® significantly improved overall blood sugar control in type 1 diabetes long-term
12 Sep 2017 FDA Accepts Adello Biologic’s Biosimilar Biologics License Application for a Proposed Filgrastim Biosimilar
12 Sep 2017 Shire’s Investigational Subcutaneous C1 esterase inhibitor (C1 INH [Human]) Liquid for Injection (SHP616) Significantly Reduces Hereditary Angioedema Monthly Attack Rate Versus Placebo in a Phase 3 Pivotal Trial
11 Sep 2017 DiaMedica Announces the Initiation of Phase 2 Trial Evaluating DM199 (Recombinant Human KLK1) in Patients with Acute Ischemic Stroke
11 Sep 2017 amcure Presents Phase I/Ib Study Design for Lead Compound AMC303 at ESMO 2017 Congress
11 Sep 2017 IRX Therapeutics Presents Positive IRX-2 Phase 2a Head and Neck Squamous Cell Carcinoma Clinical Results at the European Society for Medical Oncology Annual Congress 2017
11 Sep 2017 Radius Health Presents Positive Data for TYMLOS™ (abaloparatide) Injection from the ACTIVExtend Trial at ASBMR 2017 Annual Meeting
08 Sep 2017 ERYTECH Announces Positive Full Results from Phase 2b Study of Eryaspase in Combination with Chemotherapy for Treatment of Metastatic Pancreatic Cancer in Second-Line
07 Sep 2017 BioMarin Presents Interim Data of Phase 1/2 Study of BMN 250 for Treatment of Sanfilippo B Syndrome (MPS IIIB) at 13th International Congress of Inborn Errors of Metabolism (ICIEM) 2017
07 Sep 2017 Bayer submits marketing authorization application for BAY94-9027 for the treatment of Hemophilia A in the EU
06 Sep 2017 Aeglea BioTherapeutics Doses Two Patients in Repeat Dose Part of Phase 1/2 Clinical Trial for the Treatment of Arginase 1 Deficiency
06 Sep 2017 Catalyst Biosciences Announces Positive Factor IX Clinical Data
06 Sep 2017 Bexion Pharmaceuticals and CTI Clinical Trial and Consulting Services Announce Completion of First-in-Human Trial Using BXQ-350 for the Treatment of Cancer
05 Sep 2017 Medtronic Launches Long Term Clinical Study Program of INFUSE Bone Graft in Two Common Spine Procedures: PLF and TLIF
05 Sep 2017 Cinfa Biotech reports clinical development data for pegfilgrastim biosimilar candidate B12019 at the ESMO Congress 2017
02 Sep 2017 Sanofi Receives Tentative FDA Approval of Admelog® (insulin lispro injection) 100 Units/mL
31 Aug 2017 Oragenics Doses First Patient in Phase 2 Clinical Trial of AG013 for Oral Mucositis
31 Aug 2017 FDA Accepts Amgen's Filing Of A Supplemental New Drug Application To Add Overall Survival Results To KYPROLIS® (Carfilzomib) Label

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top